UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, announced it has been awarded a grant to research and develop an automated bioprocessing system for human tissue scaffolds.
Axogen’s partnership with the Advanced Regenerative Manufacturing Institute (ARMI) will enable the decellularization and recellularization of tissue scaffolds with little to no human intervention. The resulting bioprocessing system will have sufficient flexibility to allow customization by ARMI members for multiple decellularization and recellularization processes and multiple tissue types.
“We are pleased to have the quality of our manufacturing research and development efforts recognized through this grant award,” said Karen Zaderej, chairman, CEO, and president. “We share ARMI’s enthusiasm for creating improved tissue processing technologies that will contribute to the industry’s ability to better meet the increasing demand for tissue that can improve patient outcomes.”Learn more about Axogen Awarded Research Grant From the Advanced Regenerative Manufacturing Institute.